{"id":58353,"date":"2023-11-04T01:02:12","date_gmt":"2023-11-04T00:02:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/"},"modified":"2023-11-04T01:02:12","modified_gmt":"2023-11-04T00:02:12","slug":"healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/","title":{"rendered":"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc."},"content":{"rendered":"
\n

WINNETKA, Ill.–(BUSINESS WIRE)–Healthwell Acquisition Corp. I (\u201cHealthwell\u201d) (Nasdaq: HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with Starton Therapeutics, Inc. (\u201cStarton\u201d) was terminated by Starton. The conditions to the closing of the initial business combination were not satisfied or waived by the outside date of November 3, 2023. As a result, Healthwell will seek an alternative business combination.<\/p>\n

<\/a>
<\/a><\/p>\n

\nAbout Healthwell<\/b><\/p>\n

\nHealthwell is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.<\/p>\n

\nForward Looking Statements<\/b><\/p>\n

\nThis press release contains statements that may constitute \u201cforward-looking statements,\u201d including with respect to Healthwell\u2019s pursuit of an alternative business combination. No assurance can be given that Healthwell will be successful in seeking and consummating such alternative business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Healthwell, including those set forth in the Risk Factors section of Healthwell\u2019s public filings with the SEC. Copies are available on the SEC\u2019s website, www.sec.gov<\/a>. Healthwell undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.<\/p>\n

Contacts<\/b> <\/p>\n

\nHealthwellSPAC@edelman.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WINNETKA, Ill.–(BUSINESS WIRE)–Healthwell Acquisition Corp. I (\u201cHealthwell\u201d) (Nasdaq: HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with Starton Therapeutics, Inc. (\u201cStarton\u201d) was terminated by Starton. The conditions to the closing of the initial business combination were not satisfied or waived by the outside date of November … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58353","6":"format-standard","7":"category-industry"},"yoast_head":"\nHealthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc. - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc. - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WINNETKA, Ill.–(BUSINESS WIRE)–Healthwell Acquisition Corp. I (\u201cHealthwell\u201d) (Nasdaq: HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with Starton Therapeutics, Inc. (\u201cStarton\u201d) was terminated by Starton. The conditions to the closing of the initial business combination were not satisfied or waived by the outside date of November ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-04T00:02:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231103950518\/en\/1935151\/21\/Hwel_Logo_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.\",\"datePublished\":\"2023-11-04T00:02:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/\"},\"wordCount\":241,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231103950518\\\/en\\\/1935151\\\/21\\\/Hwel_Logo_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/\",\"name\":\"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc. - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231103950518\\\/en\\\/1935151\\\/21\\\/Hwel_Logo_%281%29.jpg\",\"datePublished\":\"2023-11-04T00:02:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231103950518\\\/en\\\/1935151\\\/21\\\/Hwel_Logo_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231103950518\\\/en\\\/1935151\\\/21\\\/Hwel_Logo_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc. - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/","og_locale":"en_US","og_type":"article","og_title":"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc. - Pharma Trend","og_description":"WINNETKA, Ill.–(BUSINESS WIRE)–Healthwell Acquisition Corp. I (\u201cHealthwell\u201d) (Nasdaq: HWEL) announced today that its previously announced Business Combination Agreement in connection with its planned business combination with Starton Therapeutics, Inc. (\u201cStarton\u201d) was terminated by Starton. The conditions to the closing of the initial business combination were not satisfied or waived by the outside date of November ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/","og_site_name":"Pharma Trend","article_published_time":"2023-11-04T00:02:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231103950518\/en\/1935151\/21\/Hwel_Logo_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc.","datePublished":"2023-11-04T00:02:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/"},"wordCount":241,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231103950518\/en\/1935151\/21\/Hwel_Logo_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/","url":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/","name":"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc. - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231103950518\/en\/1935151\/21\/Hwel_Logo_%281%29.jpg","datePublished":"2023-11-04T00:02:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231103950518\/en\/1935151\/21\/Hwel_Logo_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231103950518\/en\/1935151\/21\/Hwel_Logo_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/healthwell-acquisition-corp-i-announces-termination-of-business-combination-with-starton-therapeutics-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Healthwell Acquisition Corp. I Announces Termination of Business Combination with Starton Therapeutics, Inc."}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58353"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58353\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}